Pharmaceutical consumption in Luxembourg
Luxembourg: Pharmaceutical consumption was 640.1 Defined daily dose per 1 000 inhabitants per day in 2025. ▲ Rising
Pharmaceutical consumption in Luxembourg, 2004–2025
Source: Organisation for Economic Co-operation and Development. Measured in Defined daily dose per 1 000 inhabitants per day.
Analysis
The most recent figure for pharmaceutical consumption in Luxembourg is 640.1 Defined daily dose per 1 000 inhabitants per day, measured in 2025.
That represents a change of down 4.9% on the previous year and up 39.0% over ten years.
Over the whole period, pharmaceutical consumption in Luxembourg peaked at 673.2 Defined daily dose per 1 000 inhabitants per day in 2024 and was at its lowest, 142.3 Defined daily dose per 1 000 inhabitants per day, in 2007.
That places Luxembourg 1st out of 21 countries with data for 2025, putting it in the top 10%.
The long-run direction has been consistently rising across the 22 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 186.23 Defined daily dose per 1 000 inhabitants per day | 142.3 Defined daily dose per 1 000 inhabitants per day | 210.8 Defined daily dose per 1 000 inhabitants per day | 6 |
| 2010s | 401.71 Defined daily dose per 1 000 inhabitants per day | 249.7 Defined daily dose per 1 000 inhabitants per day | 473.3 Defined daily dose per 1 000 inhabitants per day | 10 |
| 2020s | 595.03 Defined daily dose per 1 000 inhabitants per day | 485 Defined daily dose per 1 000 inhabitants per day | 673.2 Defined daily dose per 1 000 inhabitants per day | 6 |
Countries ranked near Luxembourg
More health data for Luxembourg
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5867 % change on previous year (2090)
- Heat deaths vs projected death rates 1,220 (2090)
- Un projection of annual infant deaths 4 (2100)
- Population, male, annual growth rate 1.51 % change on previous year (2025)
- Population, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population, male, per capita 0.5035 units per person (2025)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 4,324 (2025)
Frequently asked questions
- What is pharmaceutical consumption in Luxembourg?
- Pharmaceutical consumption in Luxembourg was 640.1 Defined daily dose per 1 000 inhabitants per day in 2025, according to Organisation for Economic Co-operation and Development.
- What is the highest pharmaceutical consumption recorded in Luxembourg?
- The highest recorded value was 673.2 Defined daily dose per 1 000 inhabitants per day in 2024.
- What is the lowest pharmaceutical consumption recorded in Luxembourg?
- The lowest recorded value was 142.3 Defined daily dose per 1 000 inhabitants per day in 2007.
- How does Luxembourg rank for pharmaceutical consumption?
- Luxembourg ranks 1st out of 21 countries with data for 2025.
- Is pharmaceutical consumption rising or falling in Luxembourg?
- Over the last ten years it is up 39.0%. The long-run trend across the full record is rising.
- Where does this Luxembourg data come from?
- The figures come from Organisation for Economic Co-operation and Development, published as part of Pharmaceutical consumption. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under OECD Terms and Conditions (attribution required).
About this data
Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.